Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators [see comments]. - Ettinger,B.; Black,D.M.; Mitlak,B.H.; Knickerbocker,R.K.; Nickelsen,T.; Genant,H.K. (JAMA, 1999)